Scaling up Biodefense

The US is ramping up its capabilities for producing vaccines and other medical countermeasures to respond to epidemics, pandemics, and bioterrorism events through a $440 million initiative that is funding three centers around the country, called the Centers for Innovation in Advanced Development and Manufacturing program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.